Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Traws Pharma (TRAW) Asset Utilization Ratio (2016 - 2025)

Traws Pharma (TRAW) has disclosed Asset Utilization Ratio for 13 consecutive years, with 0.24 as the latest value for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 1714.72% year-over-year to 0.24; the TTM value through Dec 2025 reached 0.24, up 1714.72%, while the annual FY2025 figure was 0.16, 1553.18% up from the prior year.
  • Asset Utilization Ratio hit 0.24 in Q4 2025 for Traws Pharma, up from 0.2 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.24 in Q4 2025 and bottomed at 0.0 in Q4 2021.
  • Average Asset Utilization Ratio over 5 years is 0.04, with a median of 0.01 recorded in 2023.
  • Year-over-year, Asset Utilization Ratio plummeted 91.22% in 2021 and then skyrocketed 1714.72% in 2025.
  • Traws Pharma's Asset Utilization Ratio stood at 0.0 in 2021, then soared by 38.86% to 0.01 in 2022, then surged by 67.24% to 0.01 in 2023, then surged by 46.68% to 0.01 in 2024, then surged by 1714.72% to 0.24 in 2025.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.24, 0.2, and 0.17 for Q4 2025, Q3 2025, and Q2 2025 respectively.